Glucommander

JSON twin: https://www.healthaidb.com/software/glucommander.json

Company Name

Glytec

Product URL

https://glytec.com

Company URL

https://glytec.com

Categories

• clinical Care
• diagnostic Support
• administrative Operations
• patient Facing
• Clinical
• Diagnostic
• Administrative

Summary

Glucommander is an FDA-cleared, cloud-based insulin dosing software developed by Glytec, designed to optimize inpatient glycemic management through personalized dosing recommendations and seamless integration with electronic health records (EHRs).

Description

Glucommander leverages real-time and historical patient data to provide personalized insulin dosing recommendations, aiming to improve patient outcomes, reduce length of stay, and decrease the incidence of hypoglycemia in hospitalized patients. It integrates directly with EHRs, facilitating efficient workflow and minimizing redundant data entry. The software supports both intravenous (IV) and subcutaneous (SubQ) insulin therapy, and offers hospital-to-home discharge recommendations for both adult and pediatric patients. Glytec's platform is validated by over 100 patents and more than 100 publications, underscoring its clinical efficacy and safety. The company has received recognition, including being named a finalist for the 2021 Medical Design Excellence Awards and winning the 'Best Computerized Decision Support Solution' in the 2025 MedTech Breakthrough Awards. Additionally, Glytec secured a $36 million growth investment in June 2025 to accelerate the development of its AI-powered diabetes technology platform. The company has also expanded its collaboration with Roche Diagnostics to integrate Glucommander with Roche's smart-device hospital blood glucose system, cobas® pulse, aiming to enhance inpatient glycemic management globally.

Api Available

unknown

Certifications

• FDA-cleared (Glucommander)

Company Founding

2006

Company Offices

• United States
• Canada
• United Kingdom
• Germany
• France
• Italy
• Spain
• Australia
• India
• China

Compliance

• HIPAA
• HITRUST CSF
• FDA-cleared

Customers

Data Residency

US-only

Data Standards

• HL7 v2

Deployment Model

• SaaS

Features

• Personalized IV insulin dosing (Glucommander IV)
• Personalized subcutaneous insulin dosing (Glucommander SubQ)
• Clinical decision support and safety guardrails
• Real-time and historical patient data analysis
• Glycemic command center dashboards and monitoring
• Advanced analytics and benchmarking (Glytec Analytics)
• Risk identification and prediction
• Hospital-to-home discharge insulin recommendations
• Automated dose adjustments and protocols
• Reporting for financial and quality KPIs

Id

SW1405

Integration Partners

Integrations

• Epic
• Cerner / Oracle Health
• MEDITECH
• Allscripts
• Other EMRs (EHR-agnostic / custom EMR integrations)

Languages Supported

• English
• Spanish
• French
• German
• Italian
• Portuguese
• Dutch
• Russian
• Chinese
• Japanese
• Korean
• Arabic
• Hindi
• Bengali
• Punjabi
• Telugu
• Marathi
• Tamil
• Urdu
• Gujarati

Last Updated

2025-10-11

License

Commercial

Market Segment

• Enterprise
• SMB

Optional Modules

• Glytec Command Center
• Glytec Analytics
• Professional services (implementation, training, optimization)

Os Platforms

• Web

Pricing Details

Contact vendor for pricing information.

Pricing Model

Subscription

Privacy Features

• Privacy policy describing data handling
• De-identification/aggregated data sharing

Product Code

SW1405

Product Name

Glucommander

Ratings

Regions Available

• United States
• Canada
• Europe
• Asia
• Australia
• South America
• Africa
• Middle East
• India
• China
• Japan
• South Korea
• Singapore
• Malaysia
• Thailand
• Indonesia
• Philippines
• Vietnam
• Pakistan
• Bangladesh
• Sri Lanka

Related Urls

• https://elion.health/products/glytec

Release Year

""

Security Features

• Password protection
• Audit logging

Specialties

• Endocrinology
• Diabetes Care
• Critical Care
• Internal Medicine
• Pediatrics
• Geriatrics
• Cardiology
• Neurology
• Surgery
• Obstetrics
• Orthopedics
• Pulmonology
• Gastroenterology
• Nephrology
• Hematology
• Oncology
• Rheumatology
• Infectious Diseases
• Emergency Medicine
• Anesthesiology

Support Channels

System Requirements

Target Users

• Clinicians
• Nurses
• Patients
• Admins

Training Options

Type

product

User Reviews

Version

1.0

Alternatives

See related products

Canonical JSON

{
  "product_name": "Glucommander",
  "company_name": "Glytec",
  "product_url": "https://glytec.com",
  "company_url": "https://glytec.com",
  "related_urls": [
    "https://elion.health/products/glytec"
  ],
  "product_code": "SW1405",
  "summary": "Glucommander is an FDA-cleared, cloud-based insulin dosing software developed by Glytec, designed to optimize inpatient glycemic management through personalized dosing recommendations and seamless integration with electronic health records (EHRs).",
  "description": "Glucommander leverages real-time and historical patient data to provide personalized insulin dosing recommendations, aiming to improve patient outcomes, reduce length of stay, and decrease the incidence of hypoglycemia in hospitalized patients. It integrates directly with EHRs, facilitating efficient workflow and minimizing redundant data entry. The software supports both intravenous (IV) and subcutaneous (SubQ) insulin therapy, and offers hospital-to-home discharge recommendations for both adult and pediatric patients. Glytec's platform is validated by over 100 patents and more than 100 publications, underscoring its clinical efficacy and safety. The company has received recognition, including being named a finalist for the 2021 Medical Design Excellence Awards and winning the 'Best Computerized Decision Support Solution' in the 2025 MedTech Breakthrough Awards. Additionally, Glytec secured a $36 million growth investment in June 2025 to accelerate the development of its AI-powered diabetes technology platform. The company has also expanded its collaboration with Roche Diagnostics to integrate Glucommander with Roche's smart-device hospital blood glucose system, cobas® pulse, aiming to enhance inpatient glycemic management globally.",
  "categories": [
    "clinical Care",
    "diagnostic Support",
    "administrative Operations",
    "patient Facing",
    "Clinical",
    "Diagnostic",
    "Administrative",
    "Patient-facing"
  ],
  "market_segment": [
    "Enterprise",
    "SMB"
  ],
  "target_users": [
    "Clinicians",
    "Nurses",
    "Patients",
    "Admins"
  ],
  "specialties": [
    "Endocrinology",
    "Diabetes Care",
    "Critical Care",
    "Internal Medicine",
    "Pediatrics",
    "Geriatrics",
    "Cardiology",
    "Neurology",
    "Surgery",
    "Obstetrics",
    "Orthopedics",
    "Pulmonology",
    "Gastroenterology",
    "Nephrology",
    "Hematology",
    "Oncology",
    "Rheumatology",
    "Infectious Diseases",
    "Emergency Medicine",
    "Anesthesiology"
  ],
  "regions_available": [
    "United States",
    "Canada",
    "Europe",
    "Asia",
    "Australia",
    "South America",
    "Africa",
    "Middle East",
    "India",
    "China",
    "Japan",
    "South Korea",
    "Singapore",
    "Malaysia",
    "Thailand",
    "Indonesia",
    "Philippines",
    "Vietnam",
    "Pakistan",
    "Bangladesh",
    "Sri Lanka"
  ],
  "languages_supported": [
    "English",
    "Spanish",
    "French",
    "German",
    "Italian",
    "Portuguese",
    "Dutch",
    "Russian",
    "Chinese",
    "Japanese",
    "Korean",
    "Arabic",
    "Hindi",
    "Bengali",
    "Punjabi",
    "Telugu",
    "Marathi",
    "Tamil",
    "Urdu",
    "Gujarati"
  ],
  "pricing_model": "Subscription",
  "pricing_details": "Contact vendor for pricing information.",
  "license": "Commercial",
  "company_offices": [
    "United States",
    "Canada",
    "United Kingdom",
    "Germany",
    "France",
    "Italy",
    "Spain",
    "Australia",
    "India",
    "China"
  ],
  "company_founding": "2006",
  "deployment_model": [
    "SaaS"
  ],
  "os_platforms": [
    "Web"
  ],
  "features": [
    "Personalized IV insulin dosing (Glucommander IV)",
    "Personalized subcutaneous insulin dosing (Glucommander SubQ)",
    "Clinical decision support and safety guardrails",
    "Real-time and historical patient data analysis",
    "Glycemic command center dashboards and monitoring",
    "Advanced analytics and benchmarking (Glytec Analytics)",
    "Risk identification and prediction",
    "Hospital-to-home discharge insulin recommendations",
    "Automated dose adjustments and protocols",
    "Reporting for financial and quality KPIs"
  ],
  "optional_modules": [
    "Glytec Command Center",
    "Glytec Analytics",
    "Professional services (implementation, training, optimization)"
  ],
  "integrations": [
    "Epic",
    "Cerner / Oracle Health",
    "MEDITECH",
    "Allscripts",
    "Other EMRs (EHR-agnostic / custom EMR integrations)"
  ],
  "data_standards": [
    "HL7 v2"
  ],
  "api_available": "unknown",
  "system_requirements": "",
  "compliance": [
    "HIPAA",
    "HITRUST CSF",
    "FDA-cleared"
  ],
  "certifications": [
    "FDA-cleared (Glucommander)"
  ],
  "security_features": [
    "Password protection",
    "Audit logging"
  ],
  "privacy_features": [
    "Privacy policy describing data handling",
    "De-identification/aggregated data sharing"
  ],
  "data_residency": "US-only",
  "customers": [],
  "user_reviews": [],
  "ratings": [],
  "support_channels": [],
  "training_options": [],
  "release_year": "\"\"",
  "integration_partners": [],
  "id": "SW1405",
  "slug": "glucommander",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-10-11",
  "links_json": {
    "self": "https://www.healthaidb.com/software/glucommander.json"
  }
}